{"id":4614,"date":"2023-11-02T00:00:00","date_gmt":"2023-11-01T16:00:00","guid":{"rendered":"https:\/\/dailymarkup.com\/?p=4614"},"modified":"2023-11-01T00:45:13","modified_gmt":"2023-10-31T16:45:13","slug":"daily-markup-865-pandorum-technologies-advances-to-human-trials-for-bio-engineered-liquid-cornea-kuragenx-to-cure-corneal-blindness","status":"publish","type":"post","link":"https:\/\/dailymarkup.com\/?p=4614","title":{"rendered":"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness"},"content":{"rendered":"\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/lh7-us.googleusercontent.com\/z_nB8R6ZdFRtSh9_hSqRi5_naL7JuKMbTdemWIVFXEFbXx5ItjKGx_SObrOfA6X_iluSLHmzcbGuc19vdL5bfjbVkzTg6kRPmPqCQzMbrC3qSJxuLE1Hs4TKHqXg3UwM8UjsVrYBvdTWjl4kPh3VFFI\" alt=\"\" \/><figcaption class=\"wp-element-caption\">Photo credit: Pandorum Technologies<\/figcaption><\/figure>\n\n\n\n<p><strong>A natural re-vision<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Approximately 12 million people around the world are waiting for a corneal transplant. The outcomes of these transplants vary in efficacy, further emphasizing the need for better treatment options.<\/li>\n\n\n\n<li>This is a problem that 500-backed biotech firm <a href=\"https:\/\/pandorum.com\/\">Pandorum Technologies<\/a> believes they can solve with Kuragenx &#8211; a bioengineered liquid cornea designed to stimulate the repair and regeneration of damaged corneal tissue.<\/li>\n\n\n\n<li>Once a surgeon removes the diseased tissue, the viscous Kuragenx liquid is administered dropwise into the wound site, solidifies and integrates with the host cornea in a few minutes acting as \u201cscaffolding\u201d epithelial cell growth and sustained exosome release.<\/li>\n\n\n\n<li>The first in-human phase 1\/2a study of Kuragenx will take place at Northwestern University Feinberg School of Medicine and Dr Shroff\u2019s Charity Eye Hospital from 2024, starting with treatment for a small pool of patients with severe disease.<\/li>\n\n\n\n<li>Pandorum is building a pipeline of products to heal damaged tissues, including a <a href=\"https:\/\/pandorum.com\/mini-liver\/\">mini liver<\/a> and <a href=\"https:\/\/pandorum.com\/lung-regeneration\/\">lung regeneration tissue<\/a>. \u201cOur goal is to make regenerative medicine a mainstream reality and improve the lives of millions of patients suffering from a wide range of injuries and diseases.\u201d &#8211; Tuhin Bhowmick, co-founder of Pandorum Technologies.<\/li>\n\n\n\n<li>Read the full feature on <a href=\"https:\/\/bit.ly\/40hhZph\">Nature.com<\/a>.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>A natural re-vision<\/p>\n","protected":false},"author":5,"featured_media":4615,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","footnotes":""},"categories":[322],"tags":[465],"class_list":["post-4614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-daily","tag-pandorum-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness - Markup<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailymarkup.com\/?p=4614\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness - Markup\" \/>\n<meta property=\"og:description\" content=\"A natural re-vision\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailymarkup.com\/?p=4614\" \/>\n<meta property=\"og:site_name\" content=\"Markup\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/facebook.com\/500southeastasia\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-01T16:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-31T16:45:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailymarkup.com\/wp-content\/uploads\/2023\/11\/Pandorum-Technologies-Kuragenx.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1171\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ching Yee Ho\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dailymarkup.com\/#website\",\"url\":\"https:\/\/dailymarkup.com\/\",\"name\":\"Markup\",\"description\":\"Serving bite-sized news on 500 Southeast Asia&#039;s portfolio companies and insights to fuel your momentum in life and business.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dailymarkup.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailymarkup.com\/?p=4614#primaryimage\",\"url\":\"https:\/\/dailymarkup.com\/wp-content\/uploads\/2023\/11\/Pandorum-Technologies-Kuragenx.jpg\",\"contentUrl\":\"https:\/\/dailymarkup.com\/wp-content\/uploads\/2023\/11\/Pandorum-Technologies-Kuragenx.jpg\",\"width\":1920,\"height\":1171},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dailymarkup.com\/?p=4614#webpage\",\"url\":\"https:\/\/dailymarkup.com\/?p=4614\",\"name\":\"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness - Markup\",\"isPartOf\":{\"@id\":\"https:\/\/dailymarkup.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dailymarkup.com\/?p=4614#primaryimage\"},\"datePublished\":\"2023-11-01T16:00:00+00:00\",\"dateModified\":\"2023-10-31T16:45:13+00:00\",\"author\":{\"@id\":\"https:\/\/dailymarkup.com\/#\/schema\/person\/519b865263ce8210988e9676b536923f\"},\"breadcrumb\":{\"@id\":\"https:\/\/dailymarkup.com\/?p=4614#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dailymarkup.com\/?p=4614\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dailymarkup.com\/?p=4614#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dailymarkup.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/dailymarkup.com\/#\/schema\/person\/519b865263ce8210988e9676b536923f\",\"name\":\"Ching Yee Ho\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dailymarkup.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2a65dd4b61125a19ff989c4d621a9a0a8f9e7d34b0118d60e00ecec7fd41e330?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2a65dd4b61125a19ff989c4d621a9a0a8f9e7d34b0118d60e00ecec7fd41e330?s=96&d=mm&r=g\",\"caption\":\"Ching Yee Ho\"},\"url\":\"https:\/\/dailymarkup.com\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness - Markup","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailymarkup.com\/?p=4614","og_locale":"en_US","og_type":"article","og_title":"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness - Markup","og_description":"A natural re-vision","og_url":"https:\/\/dailymarkup.com\/?p=4614","og_site_name":"Markup","article_publisher":"http:\/\/facebook.com\/500southeastasia","article_published_time":"2023-11-01T16:00:00+00:00","article_modified_time":"2023-10-31T16:45:13+00:00","og_image":[{"width":1920,"height":1171,"url":"https:\/\/dailymarkup.com\/wp-content\/uploads\/2023\/11\/Pandorum-Technologies-Kuragenx.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ching Yee Ho","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/dailymarkup.com\/#website","url":"https:\/\/dailymarkup.com\/","name":"Markup","description":"Serving bite-sized news on 500 Southeast Asia&#039;s portfolio companies and insights to fuel your momentum in life and business.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailymarkup.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailymarkup.com\/?p=4614#primaryimage","url":"https:\/\/dailymarkup.com\/wp-content\/uploads\/2023\/11\/Pandorum-Technologies-Kuragenx.jpg","contentUrl":"https:\/\/dailymarkup.com\/wp-content\/uploads\/2023\/11\/Pandorum-Technologies-Kuragenx.jpg","width":1920,"height":1171},{"@type":"WebPage","@id":"https:\/\/dailymarkup.com\/?p=4614#webpage","url":"https:\/\/dailymarkup.com\/?p=4614","name":"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness - Markup","isPartOf":{"@id":"https:\/\/dailymarkup.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailymarkup.com\/?p=4614#primaryimage"},"datePublished":"2023-11-01T16:00:00+00:00","dateModified":"2023-10-31T16:45:13+00:00","author":{"@id":"https:\/\/dailymarkup.com\/#\/schema\/person\/519b865263ce8210988e9676b536923f"},"breadcrumb":{"@id":"https:\/\/dailymarkup.com\/?p=4614#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailymarkup.com\/?p=4614"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dailymarkup.com\/?p=4614#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailymarkup.com\/"},{"@type":"ListItem","position":2,"name":"Daily Markup #865: Pandorum Technologies advances to human trials for bio-engineered \u2018liquid cornea\u2019, Kuragenx, to cure corneal blindness"}]},{"@type":"Person","@id":"https:\/\/dailymarkup.com\/#\/schema\/person\/519b865263ce8210988e9676b536923f","name":"Ching Yee Ho","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dailymarkup.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2a65dd4b61125a19ff989c4d621a9a0a8f9e7d34b0118d60e00ecec7fd41e330?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a65dd4b61125a19ff989c4d621a9a0a8f9e7d34b0118d60e00ecec7fd41e330?s=96&d=mm&r=g","caption":"Ching Yee Ho"},"url":"https:\/\/dailymarkup.com\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/posts\/4614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4614"}],"version-history":[{"count":2,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/posts\/4614\/revisions"}],"predecessor-version":[{"id":4617,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/posts\/4614\/revisions\/4617"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=\/wp\/v2\/media\/4615"}],"wp:attachment":[{"href":"https:\/\/dailymarkup.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailymarkup.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}